The use of topical calcineurin inhibitors in lupus erythematosus: an overview.

@article{Wollina2008TheUO,
  title={The use of topical calcineurin inhibitors in lupus erythematosus: an overview.},
  author={Uwe Wollina and Gesina Hansel},
  journal={Journal of the European Academy of Dermatology and Venereology : JEADV},
  year={2008},
  volume={22 1},
  pages={1-6}
}
Lupus erythematosus (LE) shows a broad range of cutaneous symptoms, including acute, subacute and chronic lesions. The gold standard of established topical treatment consists of medium- to high-potency corticosteroids. Because face and neck are often involved, adverse effects of prolonged corticosteroid use are not uncommon. There is a need of steroid-free topical treatment in LE. With the development of topical calcineurin inhibitors, tacrolimus and pimecrolimus, there is an alternative… CONTINUE READING

Similar Papers

Loading similar papers…